EUVIMEDEUVIMED entdecken
EditorialKommentar

An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients

LaQuisa C Hill, Melody Smith

NEJM Evidence · 2024

DOI: 10.1056/evide2400022 ↗

Kurz gefasst

Editorial in der Zeitschrift NEJM Evidence, 2024. Verfasst von LaQuisa C Hill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston. Hauptthemen laut MEDLINE: Ethnic and Racial Minorities, Immunotherapy, Adoptive. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ethnic and Racial MinoritiesImmunotherapy, AdoptiveHumansEthnicityReceptors, Chimeric AntigenMinority GroupsFemaleMale

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston.
  • Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA.
  • Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

Zitieren

APA

Hill, L. C., & Smith, M. (2024). An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients. NEJM Evidence. https://doi.org/10.1056/evide2400022

Vancouver

Hill LC, Smith M. An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients. NEJM Evidence. 2024. doi:10.1056/evide2400022

BibTeX
@article{Hill2024,
  author = {Hill, LaQuisa C and Smith, Melody},
  title = {An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients},
  journal = {NEJM Evidence},
  year = {2024},
  doi = {10.1056/evide2400022}
}
Kostenlos starten →